{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:05:37Z","timestamp":1783631137267,"version":"3.55.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"crossref","award":["BE2018611"],"award-info":[{"award-number":["BE2018611"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20151085"],"award-info":[{"award-number":["BK20151085"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370304"],"award-info":[{"award-number":["81370304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science and technology development Foundation of Nanjing Department of Health","award":["YKK15101, ZKX16048"],"award-info":[{"award-number":["YKK15101, ZKX16048"]}]},{"name":"the 10th Summit of Six Top Talents of Jiangsu Province","award":["2016-WSN-185"],"award-info":[{"award-number":["2016-WSN-185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00109-019-01814-9","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T20:43:48Z","timestamp":1561754628000},"page":"1219-1229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Critical regulation of atherosclerosis by the KCa3.1 channel and the retargeting of this therapeutic target in in-stent neoatherosclerosis"],"prefix":"10.1007","volume":"97","author":[{"given":"Yan-Rong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-3113","authenticated-orcid":false,"given":"Dai-Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"issue":"5","key":"1814_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrcardio.2013.13","volume":"10","author":"S Garg","year":"2013","unstructured":"Garg S, Bourantas C, Serruys PW (2013) New concepts in the design of drug eluting coronary stents. Nat Rev Cardiol 10(5):248\u2013260","journal-title":"Nat Rev Cardiol"},{"key":"1814_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/srep44789","volume":"7","author":"X Yang","year":"2017","unstructured":"Yang X, Li Y, Ren X, Xiong X, Wu L, Li J, Wang J, Gao Y, Shang H, Xing Y (2017) Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Sci Rep 7:44789","journal-title":"Sci Rep"},{"key":"1814_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.yjmcc.2018.07.007","volume":"121","author":"JP Hytonen","year":"2018","unstructured":"Hytonen JP, Taavitsainen J, Laitinen J et al (2018) Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits. J Mol Cell Cardiol 121:145\u2013154","journal-title":"J Mol Cell Cardiol"},{"key":"1814_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2018.08.047","volume":"277","author":"BG Kim","year":"2018","unstructured":"Kim BG, Hong SJ, Kim BK, Ahn CM, Shin DH, Kim JS, Ko YG, Choi D, Hong MK, Jang Y (2018) Association between body mass index and clinical outcomes after new-generation drug-eluting stent implantation: Korean multi-center registry data. Atherosclerosis 277:155\u2013162","journal-title":"Atherosclerosis"},{"issue":"23","key":"1814_CR5","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","volume":"59","author":"SJ Park","year":"2012","unstructured":"Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y (2012) In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol 59(23):2051\u20132057","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"1814_CR6","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jcin.2017.06.064","volume":"10","author":"F Alfonso","year":"2017","unstructured":"Alfonso F, Cuesta J, Perez-Vizcayno MJ et al (2017) Bioresorbable vascular scaffolds for patients with in-stent restenosis: the RIBS VI study. JACC Cardiovasc Interv 10(18):1841\u20131851","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"1814_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1586\/ecp.10.11","volume":"3","author":"H Wulff","year":"2010","unstructured":"Wulff H, Castle NA (2010a) Therapeutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Rev Clin Pharmacol 3(3):385\u2013396","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1814_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.metabol.2018.01.008","volume":"83","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Ye P, Chen SL, Zhang DM (2018) Functional regulation of large conductance Ca2+-activated K+ channels in vascular diseases. Metab Clin Exp 83:75\u201380","journal-title":"Metab Clin Exp"},{"issue":"5","key":"1814_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/1570159X15666170830122402","volume":"16","author":"L Sforna","year":"2018","unstructured":"Sforna L, Megaro A, Pessia M, Franciolini F, Catacuzzeno L (2018) Structure, gating and basic functions of the Ca2+-activated K channel of intermediate conductance. Curr Neuro pharmacol 16(5):608\u2013617","journal-title":"Curr Neuro pharmacol"},{"key":"1814_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s12276-018-0043-z","volume":"50","author":"MX Gu","year":"2018","unstructured":"Gu MX, Zhu YR, Yin XR, Zhang DM (2018) Small conductance Ca2+-activated K+ channels: insights into their roles in cardiovascular diseases. Exp Mol Med 50:23","journal-title":"Exp Mol Med"},{"key":"1814_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2141.2010.08520.x","volume":"153","author":"KI Ataga","year":"2011","unstructured":"Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW, ICA-17043-10 Study Investigators (2011) Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043). Br J Haematol 153:92\u2013104","journal-title":"Br J Haematol"},{"issue":"8","key":"1814_CR12","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1182\/blood-2007-08-110098","volume":"111","author":"KI Ataga","year":"2008","unstructured":"Ataga KI, Smith WR, De Castro LM et al (2008a) Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood 111(8):3991\u20133997","journal-title":"Blood"},{"issue":"3","key":"1814_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1124\/mol.65.3.630","volume":"65","author":"H J\u00e4ger","year":"2004","unstructured":"J\u00e4ger H, Dreker T, Buck A, Giehl K, Gress T, Grissmer S (2004) Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65(3):630\u2013638","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1814_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/ATVBAHA.116.308461","volume":"37","author":"R Xu","year":"2017","unstructured":"Xu R, Li C, Wu Y, Shen L, Ma J, Qian J, Ge J (2017) Role of KCa3.1 channels in macrophage polarization and its relevance in atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 37(2):226\u2013236","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1814_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1006\/geno.1998.5333","volume":"51","author":"S Ghanshani","year":"1998","unstructured":"Ghanshani S, Coleman M, Gustavsson P, Wu ACL, Gargus J, Gutman GA, Dahl N, Mohrenweiser H, Chandy KG (1998) Human calcium-activated potassium channel gene KCNN4 maps to chromosome 19q13.2 in the region deleted in diamond-blackfan anemia. Genomics 51(1):160\u2013161","journal-title":"Genomics"},{"issue":"2","key":"1814_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4049\/jimmunol.1701170","volume":"200","author":"EM Grossinger","year":"2018","unstructured":"Grossinger EM, Kang M, Bouchareychas L et al (2018) Ca(2+)-dependent regulation of NFATc1 via KCa3.1 in inflammatory osteoclastogenesis. J Immunol 200(2):749\u2013757","journal-title":"J Immunol"},{"issue":"21","key":"1814_CR17","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/pnas.94.21.11651","volume":"94","author":"TM Ishi","year":"1997","unstructured":"Ishi TM, Silvia C, Hirschberg B et al (1997) A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 94(21):11651\u201311656","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6832","key":"1814_CR18","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/35074145","volume":"410","author":"MA Schumacher","year":"2001","unstructured":"Schumacher MA, Rivard AF, Bachinger HP et al (2001) Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+\/calmodulin. Nature 410(6832):1120\u20131124","journal-title":"Nature"},{"issue":"12","key":"1814_CR19","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1073\/pnas.1220253110","volume":"110","author":"M Zhang","year":"2013","unstructured":"Zhang M, Pascal JM, Zhang JF (2013) Unstructured to structured transition of an intrinsically disordered protein peptide in coupling Ca(2)(+)-sensing and SK channel activation. Proc Natl Acad Sci U S A 110(12):4828\u20134833","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6388","key":"1814_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1126\/science.aas9466","volume":"360","author":"CH Lee","year":"2018","unstructured":"Lee CH, Mackinnon R (2018) Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. Science 360(6388):508\u2013513","journal-title":"Science"},{"issue":"31","key":"1814_CR21","doi-asserted-by":"publisher","first-page":"21885","DOI":"10.1074\/jbc.274.31.21885","volume":"274","author":"H Rauer","year":"1999","unstructured":"Rauer H, Pennington M, Cahalan M, Chandy KG (1999) Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. J Biol Chem 274(31):21885\u201321892","journal-title":"J Biol Chem"},{"issue":"2","key":"1814_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1074\/jbc.275.2.1201","volume":"275","author":"H Rauer","year":"2000","unstructured":"Rauer H, Lanigan MD, Pennington M et al (2000) Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca2+-activated over voltage-gated K+ channels. J Biol Chem 275(2):1201\u20131208","journal-title":"J Biol Chem"},{"issue":"34","key":"1814_CR23","doi-asserted-by":"publisher","first-page":"32040","DOI":"10.1074\/jbc.M105231200","volume":"276","author":"H Wulff","year":"2001","unstructured":"Wulff H, Gutman GA, Cahalan MD, Chandy KG (2001) Delineation of the clotrimazole\/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J Biol Chem 276(34):32040\u201332045","journal-title":"J Biol Chem"},{"issue":"2","key":"1814_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000367896","volume":"22","author":"M Cui","year":"2014","unstructured":"Cui M, Qin G, Yu K, Bowers MS, Zhang M (2014) Targeting the small- and intermediate-conductance Ca-activated potassium channels: the drug-binding pocket at the channel\/calmodulin interface. Neurosignals 22(2):65\u201378","journal-title":"Neurosignals"},{"issue":"14","key":"1814_CR25","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1073\/pnas.97.14.8151","volume":"97","author":"H Wulff","year":"2000","unstructured":"Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG (2000) Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 97(14):8151\u20138156","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1814_CR26","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/blood-2002-05-1433","volume":"101","author":"JW Stocker","year":"2003","unstructured":"Stocker JW, De Franceschi L, Mcnaughton-Smith GA et al (2003) ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 101(6):2412\u20132418","journal-title":"Blood"},{"issue":"2","key":"1814_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1476-5381.2012.02143.x","volume":"168","author":"D Strobaek","year":"2013","unstructured":"Strobaek D, Brown DT, Jenkins DP et al (2013) NS6180, a new K(Ca) 3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease. Br J Pharmacol 168(2):432\u2013444","journal-title":"Br J Pharmacol"},{"key":"1814_CR28","unstructured":"Mauler F, Hinz V, Horvath E, et al. Selective intermediate-\/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective"},{"issue":"16","key":"1814_CR29","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1016\/S0960-894X(03)00560-2","volume":"13","author":"K Urbahns","year":"2003","unstructured":"Urbahns K, Horvath E, Stasch JP et al (2003) 4-Phenyl-4H-pyrans as IK(Ca) channel blockers. Bioorg Med Chem Lett 13(16):2637\u20132639","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"1814_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058614","volume":"8","author":"A Oliv\u00e1n-Viguera","year":"2013","unstructured":"Oliv\u00e1n-Viguera A, Valero MS, Murillo MD, Wulff H, Garc\u00eda-Ot\u00edn \u00c1L, Arbon\u00e9s-Mainar JM, K\u00f6hler R (2013) Novel phenolic inhibitors of small\/intermediate-conductance Ca2+-activated K+ channels, KCa3.1 and KCa2.3. PLoS One 8(3):e58614","journal-title":"PLoS One"},{"issue":"4","key":"1814_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1124\/mol.116.108068","volume":"91","author":"HM Nguyen","year":"2017","unstructured":"Nguyen HM, Singh V, Pressly B, Jenkins DP, Wulff H, Yarov-Yarovoy V (2017c) Structural insights into the atomistic mechanisms of action of small molecule inhibitors targeting the KCa3.1 channel pore. Mol Pharmacol 91(4):392\u2013402","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1814_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.yexcr.2018.05.020","volume":"369","author":"XZ Ma","year":"2018","unstructured":"Ma XZ, Pang ZD, Wang JH, Song Z, Zhao LM, du XJ, Deng XL (2018) The role and mechanism of KCa3.1 channels in human monocyte migration induced by palmitic acid. Exp Cell Res 369(2):208\u2013217","journal-title":"Exp Cell Res"},{"issue":"22","key":"1814_CR33","doi-asserted-by":"publisher","first-page":"15843","DOI":"10.1074\/jbc.M112.427187","volume":"288","author":"D Bi","year":"2013","unstructured":"Bi D, Toyama K, Lemaitre V et al (2013a) The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem 288(22):15843\u201315853","journal-title":"J Biol Chem"},{"issue":"2","key":"1814_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1586\/14737159.8.2.179","volume":"8","author":"CC Chou","year":"2008","unstructured":"Chou CC, Lunn CA, Murgolo NJ (2008) KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation? Expert Rev Mol Diagn 8(2):179\u2013187","journal-title":"Expert Rev Mol Diagn"},{"key":"1814_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.redox.2018.02.006","volume":"16","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Shen X, Jiang X, Shan H, Cimini M, Fang P, Ji Y, Park JY, Drosatos K, Yang X, Kevil CG, Kishore R, Wang H (2018) Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular relaxation: role of insufficient hydrogen sulfide. Redox Biol 16:215\u2013225","journal-title":"Redox Biol"},{"key":"1814_CR36","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.1113\/JP272729","volume":"594","author":"ME Sandison","year":"2016","unstructured":"Sandison ME, Dempster J, McCarron JG (2016) The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype: direct demonstration of phenotypic modulation. J Physiol 594:6189\u20136209","journal-title":"J Physiol"},{"issue":"9","key":"1814_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1161\/01.CIR.0000086464.04719.DD","volume":"108","author":"R K\u00f6hler","year":"2003","unstructured":"K\u00f6hler R, Wulf H, Eichler I et al (2003) Blockade of the intermediate-conductance calcium activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108(9):1119\u20131125","journal-title":"Circulation"},{"issue":"5","key":"1814_CR38","doi-asserted-by":"publisher","first-page":"H2493","DOI":"10.1152\/ajpheart.01254.2005","volume":"291","author":"DL Tharp","year":"2006","unstructured":"Tharp DL, Wamhof BR, Turk JR et al (2006) Up-regulation of intermediate-conductance Ca2+-activated K+ channel (IKCa) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 291(5):H2493\u2013H2503","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"1814_CR39","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bjp.0706793","volume":"148","author":"H Si","year":"2006","unstructured":"Si H, Grgic I, Heyken WT, Maier T, Hoyer J, Reusch HP, K\u00f6hler R (2006) Mitogenic modulation of Ca2+-activated K+ channels in proliferating A7r5 vascular smooth muscle cells. Br J Pharmacol 148(7):909\u2013917","journal-title":"Br J Pharmacol"},{"key":"1814_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.apha.2016.07.001","volume":"78","author":"WF Jackson","year":"2017","unstructured":"Jackson WF (2017) Potassium channels in regulation of vascular smooth muscle contraction and growth. Adv Pharmacol 78:89\u2013144","journal-title":"Adv Pharmacol"},{"key":"1814_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.phrs.2014.04.013","volume":"85","author":"C Freise","year":"2014","unstructured":"Freise C, Querfeld U (2014) Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34. Pharmacol Res 85:6\u201314","journal-title":"Pharmacol Res"},{"issue":"6","key":"1814_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/ATVBAHA.107.155796","volume":"28","author":"DL Tharp","year":"2008","unstructured":"Tharp DL, Wamhof BR, Wulf H et al (2008) Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 28(6):1084\u20131089","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4519","key":"1814_CR43","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.7291986","volume":"214","author":"EK Gallin","year":"1981","unstructured":"Gallin EK (1981) Voltage clamp studies in macrophages from mouse spleen cultures. Science 214(4519):458\u2013460","journal-title":"Science"},{"issue":"6","key":"1814_CR44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0006-3495(84)84080-1","volume":"46","author":"EK Gallin","year":"1984","unstructured":"Gallin EK (1984) Calcium-and voltage-activated potassium channels in human macrophages. Biophys J 46(6):821\u2013825","journal-title":"Biophys J"},{"issue":"2","key":"1814_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s002329900093","volume":"152","author":"TE Decoursey","year":"1996","unstructured":"Decoursey TE, Kim SY, Silver MR et al (1996) Ion channel expression in PMA-differentiated human THP-1 macrophages. J Membr Biol 152(2):141\u2013157","journal-title":"J Membr Biol"},{"issue":"2","key":"1814_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1085\/jgp.200910334","volume":"135","author":"N Villalonga","year":"2010","unstructured":"Villalonga N, David M, Bielanska J, Vicente R, Comes N, Valenzuela C, Felipe A (2010) Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences. J Gen Physiol 135(2):135\u2013147","journal-title":"J Gen Physiol"},{"issue":"49","key":"1814_CR47","doi-asserted-by":"publisher","first-page":"37675","DOI":"10.1074\/jbc.M605617200","volume":"281","author":"R Vicente","year":"2006","unstructured":"Vicente R, Escalada A, Villalonga N, Texid\u00f3 L, Roura-Ferrer M, Mart\u00edn-Satu\u00e9 M, L\u00f3pez-Iglesias C, Soler C, Solsona C, Tamkun MM, Felipe A (2006) Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem 281(49):37675\u201337685","journal-title":"J Biol Chem"},{"issue":"1","key":"1814_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1194\/jlr.M023846","volume":"54","author":"Y Yang","year":"2013","unstructured":"Yang Y, Wang YF, Yang XF, Wang ZH, Lian YT, Yang Y, Li XW, Gao X, Chen J, Shu YW, Cheng LX, Liao YH, Liu K (2013) Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL. J Lipid Res 54(1):34\u201343","journal-title":"J Lipid Res"},{"issue":"1","key":"1814_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2006.02.035","volume":"190","author":"A Erdogan","year":"2007","unstructured":"Erdogan A, Schaefer MB, Kuhlmann CR et al (2007) Activation of Ca2+-activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis 190(1):100\u2013105","journal-title":"Atherosclerosis"},{"issue":"5","key":"1814_CR50","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1074\/jbc.M208914200","volume":"278","author":"H Koegel","year":"2003","unstructured":"Koegel H, Kaesler S, Burgstahler R, Werner S, Alzheimer C (2003) Unexpected down-regulation of the hIK1 Ca2+-activated K+ channel by its opener 1-ethyl-2-benzimidazolinone in HaCaT keratinocytes. Inverse effects on cell growth and proliferation. J Biol Chem 278(5):3323\u20133330","journal-title":"J Biol Chem"},{"issue":"11","key":"1814_CR51","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00424-015-1694-4","volume":"467","author":"LM Zhao","year":"2015","unstructured":"Zhao LM, Wang LP, Wang HF, Ma XZ, Zhou DX, Deng XL (2015) The role of KCa3.1 channels in cardiac fibrosis induced by pressure overload in rats. Pflugers Arch 467(11):2275\u20132285","journal-title":"Pflugers Arch"},{"issue":"7","key":"1814_CR52","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.4049\/jimmunol.1500056","volume":"195","author":"KS Kim","year":"2015","unstructured":"Kim KS, Jang JH, Lin H, Choi SW, Kim HR, Shin DH, Nam JH, Zhang YH, Kim SJ (2015) Rise and fall of Kir2.2 current by TLR4 signaling in human monocytes: PKC-dependent trafficking and PI3K-mediated PIP2 decrease. J Immunol 195(7):3345\u20133354","journal-title":"J Immunol"},{"issue":"3","key":"1814_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jcmm.12705","volume":"20","author":"W Zhang","year":"2016","unstructured":"Zhang W, Lei XJ, Wang YF, Wang DQ, Yuan ZY (2016) Role of Kir2.1 in human monocyte-derived foam cell maturation. J Cell Mol Med 20(3):403\u2013412","journal-title":"J Cell Mol Med"},{"issue":"6416","key":"1814_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/362127a0","volume":"362","author":"Y Kubo","year":"1993","unstructured":"Kubo Y, Baldwin TJ, Jan YN et al (1993a) Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature 362(6416):127\u2013133","journal-title":"Nature"},{"issue":"3","key":"1814_CR55","doi-asserted-by":"publisher","first-page":"C990","DOI":"10.1152\/ajpcell.00481.2001","volume":"283","author":"M Colden-Stanfield","year":"2002","unstructured":"Colden-Stanfield M (2002) Clustering of very late antigen-4 integrins modulates K(+) currents to alter Ca(2+)-mediated monocyte function. Am J Physiol Cell Physiol 283(3):C990\u2013C1000","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"1814_CR56","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2012.11.016","volume":"226","author":"MY Ling","year":"2013","unstructured":"Ling MY, Ma ZY, Wang YY, Qi J, Liu L, Li L, Zhang Y (2013) Up-regulated ATP-sensitive potassium channels play a role in increased inflammation and plaque vulnerability in macrophages. Atherosclerosis 226(2):348\u2013355","journal-title":"Atherosclerosis"},{"issue":"10","key":"1814_CR57","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1073\/pnas.81.10.3083","volume":"81","author":"DL Ypey","year":"1984","unstructured":"Ypey DL, Clapham DE (1984) Development of a delayed outward-rectifying K+ conductance in cultured mouse peritoneal macrophages. Proc Natl Acad Sci U S A 81(10):3083\u20133087","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1814_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139243","volume":"10","author":"A Penna","year":"2015","unstructured":"Penna A, Stutzin A (2015) KCa3.1-dependent hyperpolarization enhances intracellular Ca2+ signaling induced by fMLF in differentiated U937 cells. PLoS One 10(9):e0139243","journal-title":"PLoS One"},{"key":"1814_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yjmcc.2018.09.004","volume":"123","author":"S Yang","year":"2018","unstructured":"Yang S, Ye ZM, Chen S, Luo XY, Chen SL, Mao L, Li Y, Jin H, Yu C, Xiang FX, Xie MX, Chang J, Xia YP, Hu B (2018b) MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1\/G1 in macrophages. J Mol Cell Cardiol 123:139\u2013149","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"1814_CR60","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1172\/JCI30836","volume":"118","author":"K Toyama","year":"2008","unstructured":"Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, Fujiwara Y, Mattson DL, Das S, Melvin JE, Pratt PF, Hatoum OA, Gutterman DD, Harder DR, Miura H (2008) The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 118(9):3025\u20133037","journal-title":"J Clin Invest"},{"key":"1814_CR61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fcvm.2018.00097","volume":"5","author":"JL Decano","year":"2018","unstructured":"Decano JL, Aikawa M (2018) Dynamic macrophages: understanding mechanisms of activation as guide to therapy for atherosclerotic vascular disease. Front Cardiovasc Med 5:97","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1814_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/glia.23078","volume":"65","author":"HM Nguyen","year":"2017","unstructured":"Nguyen HM, Gr\u00f6ssinger EM, Horiuchi M, Davis KW, Jin LW, Maezawa I, Wulff H (2017b) Differential Kv1.3, KCa3.1, and Kir2.1 expression in \u201cclassically\u201d and \u201calternatively\u201d activated microglia. Glia 65(1):106\u2013121","journal-title":"Glia"},{"issue":"4","key":"1814_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/19336950.2017.1300738","volume":"11","author":"HM Nguyen","year":"2017","unstructured":"Nguyen HM, Blomster LV, Christophersen P, Wulff H (2017a) Potassium channel expression and function in microglia: plasticity and possible species variations. Channels (Austin) 11(4):305\u2013315","journal-title":"Channels (Austin)"},{"issue":"3","key":"1814_CR64","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.molcel.2016.06.021","volume":"63","author":"S Panda","year":"2016","unstructured":"Panda S, Srivastava S, Li Z, Vaeth M, Fuhs SR, Hunter T, Skolnik EY (2016) Identification of PGAM5 as a mammalian protein histidine phosphatase that plays a central role to negatively regulate CD4(+) T cells. Mol Cell 63(3):457\u2013469","journal-title":"Mol Cell"},{"issue":"3","key":"1814_CR65","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","volume":"109","author":"GR Crabtre","year":"2002","unstructured":"Crabtre GR, Olson EN (2002) NFAT signaling: choreographing the social lives of cells. Cell 109(3):S67\u2013S79","journal-title":"Cell"},{"issue":"7","key":"1814_CR66","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ddr.20467","volume":"72","author":"J Lam","year":"2011","unstructured":"Lam J, Wulff H (2011) The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression. Drug Dev Res 72(7):573\u2013584","journal-title":"Drug Dev Res"},{"issue":"47","key":"1814_CR67","doi-asserted-by":"publisher","first-page":"37137","DOI":"10.1074\/jbc.M003941200","volume":"275","author":"S Ghanshani","year":"2000","unstructured":"Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA, Cahalan MD, Chandy KG (2000) Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 275(47):37137\u201337149","journal-title":"J Biol Chem"},{"issue":"15","key":"1814_CR68","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1074\/jbc.M011342200","volume":"276","author":"CM Fanger","year":"2001","unstructured":"Fanger CM, Rauer H, Neben AL, Miller MJ, Rauer H, Wulff H, Rosa JC, Ganellin CR, Chandy KG, Cahalan MD (2001) Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J Biol Chem 276(15):12249\u201312256","journal-title":"J Biol Chem"},{"issue":"11","key":"1814_CR69","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI16921","volume":"111","author":"H Wulff","year":"2003","unstructured":"Wulff H, Calabresi PA, Allie R, Yun S, Pennington M, Beeton C, Chandy KG (2003) The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest 111(11):1703\u20131713","journal-title":"J Clin Invest"},{"issue":"2","key":"1814_CR70","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4049\/jimmunol.173.2.776","volume":"173","author":"H Wulff","year":"2004","unstructured":"Wulff H, Knaus HG, Pennington M, Chandy KG (2004) K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J Immunol 173(2):776\u2013786","journal-title":"J Immunol"},{"issue":"2","key":"1814_CR71","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00424-016-1932-4","volume":"469","author":"MV Tarasov","year":"2017","unstructured":"Tarasov MV, Bystrova MF, Kotova PD, Rogachevskaja OA, Sysoeva VY, Kolesnikov SS (2017) Calcium-gated K(+) channels of the KCa1.1-and KCa3.1-type couple intracellular Ca(2+) signals to membrane hyper-polarization in mesenchymal stromal cells from the human adipose tissue. Pflugers Arch 469(2):349\u2013362","journal-title":"Pflugers Arch"},{"issue":"4","key":"1814_CR72","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1073\/pnas.0910133107","volume":"107","author":"L Di","year":"2010","unstructured":"Di L, Srivastava S, Zhdanova O (2010) et al. Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis. Proc Natl Acad Sci U S A 107(4):1541\u20131546","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1814_CR73","first-page":"2018","volume":"5906819","author":"D Ahmed","year":"2018","unstructured":"Ahmed D, Jaworski a RD et al (2018) Transcriptional profiling suggests extensive metabolic rewiring of human and mouse macrophages during early interferon alpha responses. Mediat Inflamm 5906819:2018","journal-title":"Mediat Inflamm"},{"issue":"6","key":"1814_CR74","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","volume":"157","author":"SC Whitman","year":"2000","unstructured":"Whitman SC, Ravisankar P, Elam H, Daugherty A (2000) Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E\u2212\/\u2212mice. Am J Pathol 157(6):1819\u20131824","journal-title":"Am J Pathol"},{"issue":"3","key":"1814_CR75","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/000331970405500308","volume":"55","author":"S Upadhya","year":"2004","unstructured":"Upadhya S, Mooteri S, Peckham N, Pai RG (2004) Atherogenic effect of interleukin-2 and anti-atherogenic effect of interleukin-2 antibody in apo-E-deficient mice. Angiology 55(3):289\u2013294","journal-title":"Angiology"},{"issue":"6","key":"1814_CR76","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1172\/JCI97785","volume":"128","author":"JD Proto","year":"2018","unstructured":"Proto JD, Doran AC, Subramanian M, Wang H, Zhang M, Sozen E, Rymond CC, Kuriakose G, D\u2019Agati V, Winchester R, Sykes M, Yang YG, Tabas I (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128(6):2370\u20132375","journal-title":"J Clin Invest"},{"issue":"1","key":"1814_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/xJAHA.111.000125","volume":"1","author":"E Ammirati","year":"2012","unstructured":"Ammirati E, Cianflone D, Vecchio V, Banfi M, Vermi AC, de Metrio M, Grigore L, Pellegatta F, Pirillo A, Garlaschelli K, Manfredi AA, Catapano AL, Maseri A, Palini AG, Norata GD (2012) Effector memory T cells are associated with atherosclerosis in humans and animal models. J Am Heart Assoc 1(1):27\u201341","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1814_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cei.12477","volume":"179","author":"E Ammirati","year":"2015","unstructured":"Ammirati E, Moroni F, Magnoni M, Camici PG (2015) The role of T and B cells in human atherosclerosis and atherothrombosis. Clin Exp Immunol 179(2):173\u2013187","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"1814_CR79","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.immuni.2015.05.015","volume":"42","author":"D Hu","year":"2015","unstructured":"Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P, Grassia G, MacRitchie N, Dever G, Gordon P, Burton FL, Ialenti A, Sabir SR, McInnes IB, Brewer JM, Garside P, Weber C, Lehmann T, Teupser D, Habenicht L, Beer M, Grabner R, Maffia P, Weih F, Habenicht AJR (2015) Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin beta receptors. Immunity 42(6):1100\u20131115","journal-title":"Immunity"},{"issue":"11","key":"1814_CR80","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/CIRCRESAHA.114.301137","volume":"114","author":"SK Mohanta","year":"2014","unstructured":"Mohanta SK, Yin C, Peng L, Srikakulapu P, Bontha V, Hu D, Weih F, Weber C, Gerdes N, Habenicht AJR (2014) Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ Res 114(11):1772\u20131787","journal-title":"Circ Res"},{"issue":"16","key":"1814_CR81","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1113\/JP275793","volume":"596","author":"X Ye","year":"2018","unstructured":"Ye X, Beckett T, Bagher P, Garland CJ, Dora KA (2018) VEGF-A inhibits agonist-mediated Ca(2+) responses and activation of IKCa channels in mouse resistance artery endothelial cells. J Physiol 596(16):3553\u20133566","journal-title":"J Physiol"},{"issue":"2","key":"1814_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000265680","volume":"23","author":"J Yun","year":"2010","unstructured":"Yun J, Park H, Ko JH, Lee W, Kim K, Kim T, Shin J, Kim K, Kim K, Song JH, Noh YH, Bang H, Lim I (2010) Expression of Ca2+-activated K+ channels in human dermal fibroblasts and their roles in apoptosis. Skin Pharmacol Physiol 23(2):91\u2013104","journal-title":"Skin Pharmacol Physiol"},{"key":"1814_CR83","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1113\/jphysiol.1990.sp018237","volume":"428","author":"MP Mahaut-Smith","year":"1990","unstructured":"Mahaut-Smith MP, Rink TJ, Collins SC, Sage SO (1990) Voltage-gated potassium channels and the control of membrane potential in human platelets. J Physiol 428:723\u2013735","journal-title":"J Physiol"},{"issue":"9","key":"1814_CR84","doi-asserted-by":"publisher","first-page":"H1151","DOI":"10.1152\/ajpheart.00787.2015","volume":"310","author":"FC Yap","year":"2016","unstructured":"Yap FC, Weber DS, Taylor MS, Townsley MI, Comer BS, Maylie J, Adelman JP, Lin MT (2016) Endothelial SK3 channel-associated Ca2+ microdomains modulate blood pressure. Am J Physiol Heart Circ Physiol 310(9):H1151\u2013H1163","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1814_CR85","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1159\/000488735","volume":"46","author":"H Yang","year":"2018","unstructured":"Yang H, Li X, Liu Y, Li X, Li X, Wu M, Lv X, Chunhua C, Ding X, Zhang Y (2018a) Crocin improves the endothelial function regulated by Kca3.1 through ERK and Akt signaling pathways. Cell Physiol Biochem 46(2):765\u2013780","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"1814_CR86","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","volume":"57","author":"G Nakazawa","year":"2011","unstructured":"Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R (2011) The pathology of neoatherosclerosis in human coronary implants bare-metal and drug eluting stents. J Am Coll Cardiol 57(11):1314\u20131322","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"1814_CR87","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jcin.2018.02.029","volume":"11","author":"M Joner","year":"2018","unstructured":"Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, ten Berg J, Gershlick AH, Feldman LJ, Massberg S, Kastrati A, Prevention of PRESTIGE Investigators (2018) Neoatherosclerosis in patients with coronary stent thrombosis: findings from optical coherence tomography imaging (a report of the PRESTIGE consortium). JACC Cardiovasc Interv 11(14):1340\u20131350","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"1814_CR88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","volume":"129","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R (2014) Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-and Paclitaxel-eluting stents in humans. Circulation 129(2):211\u2013223","journal-title":"Circulation"},{"issue":"2","key":"1814_CR89","first-page":"206","volume":"14","author":"G Paoletti","year":"2018","unstructured":"Paoletti G, Gomez-Lara J, Brugaletta S, \u00d1ato M, Romaguera R, Roura G, Ferreiro JL, Teruel L, Gracida M, Ortega-Paz L, Gomez-Hospital JA, Sabat\u00e9 M, Cequier \u00c0 (2018) Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up. Euro Intervention 14(2):206\u2013214","journal-title":"Euro Intervention"},{"issue":"5","key":"1814_CR90","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/01.CIR.91.5.1320","volume":"91","author":"A Pietersma","year":"1995","unstructured":"Pietersma A, Kofflard M, de Wit LE et al (1995) Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 91(5):1320\u20131325","journal-title":"Circulation"},{"issue":"5","key":"1814_CR91","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/0735-1097(92)90389-5","volume":"20","author":"RS Schwartz","year":"1992","unstructured":"Schwartz RS, Holmes DR Jr, Topol EJ (1992) The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 20(5):1284\u20131293","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1814_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/01926230500499407","volume":"34","author":"AG Touchard","year":"2006","unstructured":"Touchard AG, Schwartz RS (2006) Preclinical restenosis models: challenges and successes. Toxicol Pathol 34(1):11\u201318","journal-title":"Toxicol Pathol"},{"issue":"1","key":"1814_CR93","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193\u2013202","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1814_CR94","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med Overseas Ed 340(2):115\u2013126","journal-title":"N Engl J Med Overseas Ed"},{"issue":"2","key":"1814_CR95","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7150\/thno.7210","volume":"4","author":"RX Yin","year":"2014","unstructured":"Yin RX, Yang DZ, Wu JZ (2014) Nanoparticle drug-and gene-eluting stents for the prevention and treatment of coronary restenosis. Theranostics 4(2):175\u2013200","journal-title":"Theranostics"},{"issue":"19","key":"1814_CR96","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.ehj.2004.06.011","volume":"25","author":"K Toutouzas","year":"2004","unstructured":"Toutouzas K, Colombo A, Stefanadis C (2004) Inflammation and restenosis after percu-taneous coronary interventions. Eur Heart J 25(19):1679\u20131687","journal-title":"Eur Heart J"},{"key":"1814_CR97","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1161\/CIRCULATIONAHA.110.988436","volume":"123","author":"SJ Kang","year":"2011","unstructured":"Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ (2011) Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug eluting stent implantation. Circulation 123:2954\u20132963","journal-title":"Circulation"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01814-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01814-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01814-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T02:19:20Z","timestamp":1593224360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01814-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":97,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01814-9","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"7 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}